Glauco Akelinghton Freire Vitiello

10PUBLICATIONS
53CO-AUTHORS
Electrical energy generation (incl. renewables, excl. photovoltaics)Cancer therapy (excl. chemotherapy and radiation therapy)Innate immunityPredictive and prognostic markersHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Apr 05, 2025
Unveiling the Dynamics of SARS-CoV-2 Gamma and Delta Waves in Paraná, Brazil - Delta Displacing a Persistent Gamma Through Alternative Routes of Dispersal.

Emanuele Gustani-Buss, Carlos Eduardo Buss, Carlos Alberto Oliveira de Biagi

|Feb 19, 2025
Targeting PRC2 Enhances the Cytotoxic Capacity of Anti-CD19 CAR T Cells against Hematologic Malignancies.

Maria Leticia Rodrigues Carvalho, Clara de Oliveira Andrade, Mariela Pires Cabral-Piccin

|May 27, 2023
APOBEC3A/B Polymorphism Is Not Associated with Human Papillomavirus Infection and Cervical Carcinogenesis.

Eliza Pizarro Castilha, Rafaela Roberta de Jaime Curti, Janaina Nicolau de Oliveira

|Mar 29, 2023
Involvement of APOBEC3A/B Deletion in Mouse Mammary Tumor Virus (MMTV)-like Positive Human Breast Cancer.

Nathália de Sousa Pereira, Glauco Akelinghton Freire Vitiello, Marla Karine Amarante

|Dec 23, 2020
Mouse Mammary Tumor Virus (MMTV)-Like env Sequence in Brazilian Breast Cancer Samples: Implications in Clinicopathological Parameters in Molecular Subtypes.

Nathália de Sousa Pereira, Glauco Akelinghton Freire Vitiello, Bruna Karina Banin-Hirata

|Apr 15, 2020
Germline APOBEC3B deletion influences clinicopathological parameters in luminal-A breast cancer: evidences from a southern Brazilian cohort.

Glauco Akelinghton Freire Vitiello, Nathalia de Sousa Pereira, Marla Karine Amarante

Pageof 2